Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00139217 · ClinicalTrials.gov registry record · NA
NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT00139217 is a NA study that has completed, run by Emory University. The registered enrollment target is 400 participants.
The verdict
NCT00139217, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
The primary objective of the trial is to determine the feasibility and clinical safety and efficacy of non-invasive inhaled nitric oxide in infants with PPHN without significant pulmonary +-parenchymal disease who would normally receive inhaled nitric oxide only after placement of a tracheal tube and the institution of mechanical ventilation.
Interventions
- DRUG iNO
- PROCEDURE Non-invasive nitric oxide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2005-08 |
| Est. Completion | 2007-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00139217
The ClinicalTrials.gov registry entry for NCT00139217 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which iNO is the first listed.
NCT00139217 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00139217 about?
NCT00139217 is a clinical study titled "NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn". The primary objective of the trial is to determine the feasibility and clinical safety and efficacy of non-invasive inhaled nitric oxide in infants with PPHN without significant pulmonary +-parenchymal disease who would normally receive inhaled nitric oxide only after placement of a tracheal tube an...
What is the current status of trial NCT00139217?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2005-08. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00139217?
The interventions under investigation include: iNO (DRUG), Non-invasive nitric oxide (PROCEDURE).
Who is sponsoring clinical trial NCT00139217?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.